Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 227.88M
March 31, 2026 231.43M
December 31, 2025 234.81M
September 30, 2025 234.81M
June 30, 2025 233.58M
March 31, 2025 233.52M
December 31, 2024 235.71M
September 30, 2024 236.50M
June 30, 2024 234.35M
March 31, 2024 234.30M
December 31, 2023 234.29M
September 30, 2023 233.79M
June 30, 2023 233.79M
March 31, 2023 233.62M
December 31, 2022 211.66M
September 30, 2022 211.75M
June 30, 2022 211.11M
March 31, 2022 211.09M
December 31, 2021 211.07M
September 30, 2021 191.87M
June 30, 2021 191.45M
March 31, 2021 191.21M
December 31, 2020 175.03M
September 30, 2020 175.14M
June 30, 2020 175.14M
Date Value
March 31, 2020 174.70M
December 31, 2019 122.57M
September 30, 2019 122.38M
June 30, 2019 122.38M
March 31, 2019 122.34M
December 31, 2018 122.34M
September 30, 2018 122.45M
June 30, 2018 122.20M
March 31, 2018 122.20M
December 31, 2017 122.20M
September 30, 2017 121.20M
June 30, 2017 119.25M
March 31, 2017 119.13M
December 31, 2016 118.86M
September 30, 2016 117.31M
June 30, 2016 117.29M
March 31, 2016 106.44M
December 31, 2015 106.26M
September 30, 2015 105.56M
June 30, 2015 105.47M
March 31, 2015 105.17M
December 31, 2014 104.94M
September 30, 2014 99.10M
June 30, 2014 99.03M
March 31, 2014 98.96M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Evaxion AS 8.340M
Genmab A/S 597.02M
Ascendis Pharma A/S 65.67M
Zealand Pharma A/S 69.81M
Agenus, Inc. 42.62M